English
简体中文
Total: £ 56.28
2025-11-06 | Pages: 173 | Tables: 174
The global Recombinant MAPK Protein market is projected to grow from US$ 293 million in 2024 to US$ 565 million by 2031, at a CAGR of 10.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff ...
2025-11-06 | Pages: 157 | Tables: 169
The global Phospho Specific Antibody market is projected to grow from US$ 707 million in 2024 to US$ 1287 million by 2031, at a CAGR of 9.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff...
2025-11-06 | Pages: 136 | Tables: 143
The global Recombinant PKB/Akt Protein market is projected to grow from US$ 6.3 million in 2024 to US$ 10.7 million by 2031, at a CAGR of 8.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tari...
2025-11-06 | Pages: 148 | Tables: 139
The global Pan-PI3K Inhibitor market is projected to grow from US$ 1420 million in 2024 to US$ 2603 million by 2031, at a CAGR of 9.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff polic...
2025-11-06 | Pages: 146 | Tables: 142
The global Pertussis Booster Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies int...
2025-11-06 | Pages: 143 | Tables: 139
The global Inhibitor of κB market is projected to grow from US$ 1059 million in 2024 to US$ 1469 million by 2031, at a CAGR of 4.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies...
2025-11-06 | Pages: 161 | Tables: 159
The global Protein Kinase C Inhibitor market is projected to grow from US$ 633 million in 2024 to US$ 946 million by 2031, at a CAGR of 6.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff...
2025-11-06 | Pages: 135 | Tables: 141
The global N-Formyl Peptide market is projected to grow from US$ 27.1 million in 2024 to US$ 43.9 million by 2031, at a CAGR of 7.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policie...
2025-11-06 | Pages: 117 | Tables: 125
The global Gum Swelling and Analgesic Drugs market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.From a downstream perspective, Ho...
2025-11-06 | Pages: 152 | Tables: 169
The global Probiotic for Kids market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce ...
2025-11-06 | Pages: 159 | Tables: 161
The global Anti-Inflammatory and Analgesic Gel market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff po...
2025-11-06 | Pages: 164 | Tables: 155
The global NAD+Anti-Ageing Supplements market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies i...
2025-11-06 | Pages: 140 | Tables: 141
The global Compound Glycyrrhizin Tablets and Capsule market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tar...
2025-11-06 | Pages: 132 | Tables: 145
The global Compound Glycyrrhizin Tablets market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies...
2025-11-06 | Pages: 169 | Tables: 162
The global Pain Relief Gel market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce tra...
